Skip to main content
SpringerLink
Log in

Treatment of meningococcal disease

  • Chapter
  • First Online:
Handbook of Meningococcal Disease Management

Abstract

Prompt recognition of meningococcal infection and aggressive early treatment are the only measures proven to be effective in treating this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 49.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Booy R, Habibi P, Nadel S, et al. Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch Dis Child. 2001;85:386–390.

    Google Scholar 

  2. Sinha R, Nadel S. Understanding shock. Paediatr Child Health. 2013;23:187–193.

    Google Scholar 

  3. Faust SN, Levin M, Harrison OB, et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med. 2001;345:408–416.

    Google Scholar 

  4. Esmon CT. The interactions between inflammation and coagulation. Br J Haematol. 2005;131:417–430.

    Google Scholar 

  5. Pathan N, Hemingway CA, Alizadeh AA, et al. Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet. 2004;363:203–209.

    Google Scholar 

  6. Cartwright K, Reilly S, White D, Stuart J. Early treatment with parenteral penicillin in meningococcal disease. BMJ. 1992;305:143–147.

    Google Scholar 

  7. Norgard B, Sorensen HT, Jensen ES, Faber T, Schonheyder HC, Nielsen GL. Pre-hospital parenteral antibiotic treatment of meningococcal disease and case fatality: a Danish population-based cohort study. J Infect. 2002;45:144–151.

    Google Scholar 

  8. Sorensen HT, Nielsen GL, Schonheyder HC, et al. Outcome of pre-hospital antibiotic treatment of meningococcal disease. J Clin Epidemiol. 1998;51:717–721.

    Google Scholar 

  9. Harnden A, Ninis N, Thompson M, et al. Parenteral penicillin for children with meningococcal disease before hospital admission: case-control study. BMJ. 2006;332:1295–1298.

    Google Scholar 

  10. Brandtzaeg P, Kierulf P, Gaustad P, et al. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis. 1989;159:195–204.

    Google Scholar 

  11. Bacterial meningitis and meningococcal septicaemia: management of bacterial meningitis and meningococcal septicaemia in children and young people younger than 16years in primary and secondary care. National Insititute for Health and Care Excellence website. www.nice.org.uk/guidance/CG102. Accessed January 29, 2015.

  12. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580–637.

    Google Scholar 

  13. Riordan FA, Marzouk O, Thomson AP, Sills JA, Hart CA. Prospective validation of the Glasgow Meningococcal Septicaemia Prognostic Score. Comparison with other scoring methods. Eur J Pediatr. 2002;161:531–537.

    Google Scholar 

  14. Carcillo JA, Davis AL, Zaritsky A. Role of early fluid resuscitation in pediatric septic shock. JAMA. 1991;266:1242–1245.

    Google Scholar 

  15. de Oliveira CF, de Oliveira DS, Gottschald AF, et al. ACCM/PALS haemodynamic support guidelines for paediatric septic shock: an outcomes comparison with and without monitoring central venous oxygen saturation. Intensive Care Med. 2008;34:1065–1075.

    Google Scholar 

  16. Rivers E, Nguyen B, Havstad S, et al. Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368–1377.

    Google Scholar 

  17. Cruz AT, Perry AM, Williams EA, Graf JM, Wuestner ER, Patel B. Implementation of goaldirected therapy for children with suspected sepsis in the emergency department. Pediatrics. 2011;127:e758–766.

    Google Scholar 

  18. Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010;303:739–746.

    Google Scholar 

  19. Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011;39:259–265.

    Google Scholar 

  20. Choong K, Bohn D, Fraser DD, et al. Vasopressin in pediatric vasodilatory shock: a multicenter randomized controlled trial. Am J Respir Crit Care Med. 2009;180:632–639.

    Google Scholar 

  21. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res. 1994;28:34–39.

    Google Scholar 

  22. Qu L, Kiss JE, Dargo G, Carcillo JA. Outcomes of previously healthy pediatric patients with fulminant sepsis-induced multisystem organ failure receiving therapeutic plasma exchange. J Clin Apher. 2011;26:208–213.

    Google Scholar 

  23. Wakai A, McCabe A, Roberts I, Schierhout G. Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev. 2013;8:CD001049.

    Google Scholar 

  24. Kumar R, Singhi S, Singhi P, Jayashree M, Bansal A, Bhatti A. Randomized controlled trial comparing cerebral perfusion pressure-targeted therapy versus intracranial pressuretargeted therapy for raised intracranial pressure due to acute CNS infections in children. Crit Care Med. 2014;42:1775–1787.

    Google Scholar 

  25. Mourvillier B, Tubach F, van de Beek D, et al. Induced hypothermia in severe bacterial meningitis: a randomized clinical trial. JAMA. 2013;310:2174–2183.

    Google Scholar 

  26. Lefering R, Neugebauer EA. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med. 1995;23:1294–1303.

    Google Scholar 

  27. De Kleijn ED, Joosten KF, Van Rijn B, et al. Low serum cortisol in combination with high adrenocorticotrophic hormone concentrations are associated with poor outcome in children with severe meningococcal disease. Pediatr Infect Dis J. 2002;21:330–336.

    Google Scholar 

  28. Derkx B, Wittes J, McCloskey R. Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group. Clin Infect Dis. 1999;28:770–777.

    Google Scholar 

  29. Levin M, Quint PA, Goldstein B, et al. Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group. Lancet. 2000;356:961–967.

    Google Scholar 

  30. Nadel S, Goldstein B, Williams MD, et al. Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial. Lancet. 2007;369:836–843.

    Google Scholar 

  31. Parshuram CS, Duncan HP, Joffe AR, et al. Multicentre validation of the bedside paediatric early warning system score: a severity of illness score to detect evolving critical illness in hospitalised children. Crit Care. 2011;15:R184.

    Google Scholar 

  32. Ninis N, Phillips C, Bailey L, et al. The role of healthcare delivery in the outcome of meningococcal disease in children: case-control study of fatal and non-fatal cases. BMJ. 2005;330:1475.

    Google Scholar 

  33. Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med. 2010;36:222–231.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. St Mary’s and Imperial College London, London, UK

    Simon Nadel

  2. University of Pittsburgh Medical Center, Pittsburgh, USA

    Joseph Carcillo

Authors
  1. Simon Nadel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph Carcillo
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. NI for Biological Standards and Con, South Mimms, Potters Bar, United Kingdom

    Ian Feavers

  2. University of Oxford, Department of Paediatrics, Oxford, Oxfordshire, United Kingdom

    Andrew J Pollard

  3. University of Oxford, Department of Paediatrics, Oxford, Oxfordshire, United Kingdom

    Manish Sadarangani

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Nadel, S., Carcillo, J. (2016). Treatment of meningococcal disease. In: Feavers, I., Pollard, A., Sadarangani, M. (eds) Handbook of Meningococcal Disease Management. Adis, Cham. https://doi.org/10.1007/978-3-319-28119-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-28119-3_6

  • Published:

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-08627-9

  • Online ISBN: 978-3-319-28119-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation